Complete Filing Data
EXOZYMES INC. reported Stockholders Equity of $3.40 million for FY2025.
All values from 10-K, 20-F, and 10-Q filings on SEC EDGAR, organized by financial statement. Scroll each table horizontally for the full history. Blank cells mean EXOZYMES INC. did not report that metric for that period in XBRL — often because accounting standards changed which tag a company files under (for example, most companies moved revenue to the ASC-606 tag in 2018), so a metric may continue in a different row. Rows marked * merge those successor tags into one continuous series, preferring the audited value from the newest-standard tag where periods overlap.
Income Statement
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 |
|---|---|---|---|
| Net Income Loss | -$9.2M | -$5.9M | -$2.0M |
| Research And Development Expense | $3.7M | $1.9M | $527.5K |
| Other General And Administrative Expense | $836.1K | $329.7K | $284.5K |
| Operating Income Loss | -$9.7M | -$5.9M | -$1.8M |
| Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest | -$9.3M | -$5.9M | -$2.0M |
| General And Administrative Expense | $6.0M | $4.1M | $1.3M |
| Interest Income Expense Nonoperating Net | $363.8K | $77.6K | $100.00 |
| Other Nonoperating Income Expense | $88.7K | -$6.8K | |
| Income Tax Expense Benefit | -$105.2K | $42.3K | |
| Income Taxes Paid Net | $63.6K | ||
| Interest Expense | |||
| Revenue From Contract With Customer Excluding Assessed Tax | $70.1K |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q3 2025 | Q2 2025 | Q1 2025 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 |
|---|---|---|---|---|---|---|---|---|---|
| Net Income Loss | -$2.3M | -$2.4M | -$1.9M | -$1.7M | -$1.4M | -$1.0M | -$520.6K | -$178.1K | -$241.2K |
| Research And Development Expense | $1.2M | $803.0K | $575.0K | $723.5K | $237.4K | $277.6K | $27.9K | ||
| Other General And Administrative Expense | $214.2K | $265.4K | $204.2K | $56.9K | $60.0K | $80.4K | $145.2K | ||
| Operating Income Loss | -$2.5M | -$2.5M | -$2.0M | -$1.6M | -$1.3M | -$1.0M | -$391.8K | ||
| Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest | -$2.3M | -$2.4M | -$1.9M | -$1.7M | -$1.4M | -$1.0M | -$520.6K | ||
| General And Administrative Expense | $1.3M | $1.7M | $1.4M | $888.2K | $1.1M | $730.9K | $363.9K | ||
| Interest Income Expense Nonoperating Net | $59.2K | $76.6K | $94.3K | -$44.6K | -$29.8K | ||||
| Other Nonoperating Income Expense | $176.0K | $111.2K | |||||||
| Income Tax Expense Benefit | $2.1K | ||||||||
| Income Taxes Paid Net | |||||||||
| Interest Expense | $44.6K | ||||||||
| Revenue From Contract With Customer Excluding Assessed Tax |
Balance Sheet
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 | FY2022 |
|---|---|---|---|---|
| Stockholders Equity | $3.4M | $10.4M | -$384.3K | $1.4M |
| Grants Receivable Current | $517.4K | $737.3K | $882.3K | $809.5K |
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents | $3.0M | $9.7M | $66.5K | $558.6K |
| Retained Earnings Accumulated Deficit | -$21.1M | -$11.9M | -$6.1M | |
| Property Plant And Equipment Net | $764.4K | $882.4K | $753.4K | |
| Prepaid Expense And Other Assets Current | $382.9K | $363.8K | $264.8K | |
| Operating Lease Right Of Use Asset | $1.1M | $1.3M | $1.6M | |
| Operating Lease Liability Noncurrent | $852.6K | $1.2M | $1.4M | |
| Operating Lease Liability Current | $282.0K | $230.0K | $225.0K | |
| Noncash Lease Expense | $53.4K | $35.0K | $10.6K | |
| Liabilities Current | $1.6M | $1.3M | $2.4M | |
| Liabilities And Stockholders Equity | $6.0M | $13.0M | $3.6M | |
| Liabilities | $2.6M | $2.6M | $3.9M | |
| Deferred Income Noncurrent | $90.4K | $123.6K | $140.7K | |
| Common Stock Value | $8.00 | $8.00 | $6.00 | |
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect | -$6.7M | $9.7M | -$492.0K | |
| Cash And Cash Equivalents At Carrying Value | $3.0M | $9.7M | $66.5K | |
| Assets Current | $3.9M | $10.8M | $1.2M | |
| Assets | $6.0M | $13.0M | $3.6M | |
| Accounts Payable Current | $1.2M | $924.3K | $702.9K | |
| Other Liabilities Current | $5.3K | $179.0K | $445.1K | |
| Finance Lease Right Of Use Asset | $108.7K | |||
| Finance Lease Liability Noncurrent | $64.4K | |||
| Finance Lease Liability Current | $44.3K | |||
| Change In Fair Value Of Simple Agreement For Future Equity | -$8.00 | -$200.0K | ||
| Taxes Payable Current | $42.3K |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q3 2025 | Q2 2025 | Q1 2025 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 |
|---|---|---|---|---|---|---|---|---|---|
| Stockholders Equity | $5.4M | $7.2M | $8.9M | -$3.6M | -$2.3M | -$1.2M | $607.1K | $1.1M | $1.2M |
| Grants Receivable Current | $302.6K | $257.4K | $595.2K | $554.0K | $1.1M | $1.1M | $676.5K | ||
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents | $5.1M | $7.0M | $8.5M | $233.9K | $158.2K | $113.8K | $474.6K | ||
| Retained Earnings Accumulated Deficit | -$18.4M | -$16.2M | -$13.8M | -$10.1M | |||||
| Property Plant And Equipment Net | $763.0K | $821.3K | $843.0K | $739.6K | |||||
| Prepaid Expense And Other Assets Current | $204.7K | $287.4K | $312.2K | $634.7K | |||||
| Operating Lease Right Of Use Asset | $1.1M | $1.2M | $1.3M | $1.4M | |||||
| Operating Lease Liability Noncurrent | $926.6K | $1.0M | $1.1M | $1.2M | |||||
| Operating Lease Liability Current | $274.3K | $243.7K | $236.8K | $223.8K | |||||
| Noncash Lease Expense | $7.3K | $9.6K | |||||||
| Liabilities Current | $1.2M | $1.2M | $1.4M | $5.8M | |||||
| Liabilities And Stockholders Equity | $7.7M | $9.7M | $11.5M | $3.6M | |||||
| Liabilities | $2.3M | $2.4M | $2.6M | $7.2M | |||||
| Deferred Income Noncurrent | $103.1K | $116.1K | $110.1K | $137.0K | |||||
| Common Stock Value | $8.00 | $8.00 | $8.00 | $6.00 | |||||
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect | -$1.2M | $47.3K | |||||||
| Cash And Cash Equivalents At Carrying Value | $5.1M | $7.0M | $8.5M | $233.9K | |||||
| Assets Current | $5.6M | $7.5M | $9.4M | $1.4M | |||||
| Assets | $7.7M | $9.7M | $11.5M | $3.6M | |||||
| Accounts Payable Current | $904.4K | $930.6K | $1.1M | $908.6K | |||||
| Other Liabilities Current | $17.1K | $135.7K | |||||||
| Finance Lease Right Of Use Asset | $119.2K | $129.6K | |||||||
| Finance Lease Liability Noncurrent | $76.6K | $87.0K | |||||||
| Finance Lease Liability Current | $42.6K | $42.6K | |||||||
| Change In Fair Value Of Simple Agreement For Future Equity | |||||||||
| Taxes Payable Current |
Cash Flow Statement
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 |
|---|---|---|---|
| Share Based Compensation | $2.0M | $1.1M | $281.5K |
| Payments To Acquire Property Plant And Equipment | $169.9K | $396.5K | $288.7K |
| Net Cash Provided By Used In Operating Activities | -$6.5M | -$8.5M | -$1.2M |
| Net Cash Provided By Used In Investing Activities | -$150.2K | -$359.2K | -$311.2K |
| Increase Decrease In Prepaid Deferred Expense And Other Assets | $19.1K | $99.0K | $163.6K |
| Increase Decrease In Accounts Receivable | -$219.9K | -$145.0K | $72.8K |
| Increase Decrease In Accounts Payable And Other Operating Liabilities | $311.1K | $221.3K | $272.9K |
| Proceeds From Deferred Grant Reimbursement | $19.7K | $37.2K | -$22.5K |
| Net Cash Provided By Used In Financing Activities | -$27.7K | $18.5M | $1.0M |
| Adjustments To Additional Paid In Capital Share Based Compensation Stock Options Requisite Service Period Recognition | $1.6M | $1.1M | $281.5K |
| Increase Decrease In Due To Related Parties | -$26.5K | -$4.2M | $205.1K |
| Increase Decrease In Accrued Taxes Payable | -$42.3K | -$21.3K | |
| Proceeds From Repayments Of Related Party Debt | $4.0M | ||
| Proceeds From Related Party Debt | $4.0M | $200.0K | |
| Proceeds From Issuance Of Common Stock | $0.00 | $14.5M | |
| Proceeds From Deferred IPO Costs | |||
| Stock Issued During Period Value Share Based Compensation | $243.8K |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q2 2025 | Q1 2025 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 |
|---|---|---|---|---|---|---|---|---|
| Share Based Compensation | $317.3K | $142.8K | ||||||
| Payments To Acquire Property Plant And Equipment | $31.0K | $148.8K | ||||||
| Net Cash Provided By Used In Operating Activities | -$1.1M | $281.2K | ||||||
| Net Cash Provided By Used In Investing Activities | -$31.0K | -$142.4K | ||||||
| Increase Decrease In Prepaid Deferred Expense And Other Assets | -$51.6K | $56.0K | ||||||
| Increase Decrease In Accounts Receivable | -$142.1K | $229.3K | ||||||
| Increase Decrease In Accounts Payable And Other Operating Liabilities | $147.5K | $53.8K | ||||||
| Proceeds From Deferred Grant Reimbursement | $6.4K | |||||||
| Net Cash Provided By Used In Financing Activities | -$43.3K | -$91.5K | ||||||
| Adjustments To Additional Paid In Capital Share Based Compensation Stock Options Requisite Service Period Recognition | $317.3K | $348.3K | $142.8K | $61.4K | $58.9K | $54.1K | ||
| Increase Decrease In Due To Related Parties | $1.3M | |||||||
| Increase Decrease In Accrued Taxes Payable | -$1.3K | |||||||
| Proceeds From Repayments Of Related Party Debt | -$43.3K | |||||||
| Proceeds From Related Party Debt | ||||||||
| Proceeds From Issuance Of Common Stock | ||||||||
| Proceeds From Deferred IPO Costs | -$91.5K | |||||||
| Stock Issued During Period Value Share Based Compensation | $243.8K |
Per-Share & Share Counts
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 |
|---|---|---|---|
| Weighted Average Number Of Shares Outstanding Basic | 8.4M | 6.6M | 6.3M |
| Weighted Average Number Of Diluted Shares Outstanding | 8.4M | 6.6M | 6.3M |
| Earnings Per Share Diluted | $-1.09 | $-0.89 | $-0.33 |
| Earnings Per Share Basic | $-1.09 | $-0.89 | $-0.33 |
| Preferred Stock Shares Outstanding | 0.00 | 0.00 | 0.00 |
| Preferred Stock Shares Issued | 0.00 | 0.00 | 0.00 |
| Preferred Stock Shares Authorized | 5.0M | 5.0M | 5.0M |
| Preferred Stock Par Or Stated Value Per Share | $0.00 | $0.00 | $0.00 |
| Common Stock Shares Outstanding | 8.4M | 8.4M | 6.3M |
| Common Stock Shares Issued | 8.4M | 8.4M | 6.3M |
| Common Stock Shares Authorized | 100.0M | 100.0M | 100.0M |
| Common Stock Par Or Stated Value Per Share | $0.00 | $0.00 | $0.00 |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q3 2025 | Q2 2025 | Q1 2025 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 |
|---|---|---|---|---|---|---|---|
| Weighted Average Number Of Shares Outstanding Basic | 8.4M | 8.4M | 8.4M | 6.3M | 6.3M | 6.3M | 6.3M |
| Weighted Average Number Of Diluted Shares Outstanding | 8.4M | 8.4M | 8.4M | 6.3M | 6.3M | 6.3M | 6.3M |
| Earnings Per Share Diluted | $-0.27 | $-0.28 | $-0.22 | $-0.27 | $-0.22 | $-0.16 | $-0.08 |
| Earnings Per Share Basic | $-0.27 | $-0.28 | $-0.22 | $-0.27 | $-0.22 | $-0.16 | $-0.08 |
| Preferred Stock Shares Outstanding | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Preferred Stock Shares Issued | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Preferred Stock Shares Authorized | 5.0M | 5.0M | 5.0M | 5.0M | |||
| Preferred Stock Par Or Stated Value Per Share | $0.00 | $0.00 | $0.00 | $0.00 | |||
| Common Stock Shares Outstanding | 8.4M | 8.4M | 8.4M | 6.3M | |||
| Common Stock Shares Issued | 8.4M | 8.4M | 8.4M | 6.3M | |||
| Common Stock Shares Authorized | 100.0M | 100.0M | 100.0M | 100.0M | |||
| Common Stock Par Or Stated Value Per Share | $0.00 | $0.00 | $0.00 | $0.00 |
Other Metrics
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2025 | FY2024 | FY2023 |
|---|---|---|---|
| Professional Fees | $1.4M | $1.2M | $436.3K |
| Operating Costs And Expenses | $9.7M | $5.9M | $1.9M |
| Labor And Related Expense | $3.6M | $2.5M | $596.2K |
| Information Technology And Data Processing | $96.0K | $38.7K | $21.8K |
| Depreciation | $288.0K | $267.4K | $196.9K |
| Adjustments To Additional Paid In Capital Stock Options | |||
| Additional Paid In Capital | $24.5M | $22.4M | $5.7M |
| Adjustment For Amortization | -$52.9K | -$54.4K | -$51.8K |
| Stock Issued During Period Shares Stock Options Exercised | 11.6K | 2.6K | |
| Derivative Gain Loss On Derivative Net | -$8.00 | -$200.0K | |
| Stock Issued During Period Value New Issues | $14.5M | ||
| Interest Paid Net | $6.3K |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q3 2025 | Q2 2025 | Q1 2025 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 |
|---|---|---|---|---|---|---|---|
| Professional Fees | $237.9K | $368.9K | $532.2K | $269.5K | $289.9K | $256.6K | $92.5K |
| Operating Costs And Expenses | $2.5M | $2.5M | $2.0M | $1.6M | $1.3M | $1.0M | $391.8K |
| Labor And Related Expense | $845.2K | $1.1M | $613.9K | $546.1K | $731.6K | $390.0K | $119.1K |
| Information Technology And Data Processing | $8.2K | $41.8K | $25.3K | $15.7K | $9.7K | $3.9K | $7.0K |
| Depreciation | $70.5K | $68.9K | $62.8K | $49.7K | |||
| Adjustments To Additional Paid In Capital Stock Options | $425.7K | $323.5K | $317.3K | $317.3K | $348.3K | $142.8K | |
| Additional Paid In Capital | $23.8M | $23.4M | $22.7M | $6.5M | |||
| Adjustment For Amortization | -$13.5K | -$13.2K | |||||
| Stock Issued During Period Shares Stock Options Exercised | |||||||
| Derivative Gain Loss On Derivative Net | -$128.8K | ||||||
| Stock Issued During Period Value New Issues | $243.8K | ||||||
| Interest Paid Net |
Most recent annual filing with the SEC: March 30, 2026
Data sourced from SEC EDGAR public filings as of August 4, 2026.